Rapt Therapeutics, Inc. (RAPT)
34.00
+0.78
(+2.35%)
USD |
NASDAQ |
Dec 16, 16:00
34.00
0.00 (0.00%)
After-Hours: 17:28
Rapt Therapeutics Cash from Investing (Quarterly): 8.466M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Replimune Group, Inc. | 84.17M |
| Olema Pharmaceuticals, Inc. | 17.27M |
| NovaBay Pharmaceuticals, Inc. | 0.00 |
| Palatin Technologies, Inc. | 0.00 |
| Theriva Biologics, Inc. | -0.019M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -12.46M |
| Cash from Financing (Quarterly) | 0.036M |
| Free Cash Flow | -86.66M |
| Free Cash Flow Per Share (Quarterly) | -0.462 |
| Free Cash Flow to Equity (Quarterly) | -11.89M |
| Free Cash Flow to Firm (Quarterly) | -12.46M |
| Free Cash Flow Yield | -3.23% |